Blog
RSS FeedPosted by Michael Wonder on 26 Apr 2021
EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe
26 April 2021 - The EMA and the European Centre for Disease Prevention and Control today kicked off a new ...
Posted by Michael Wonder on 25 Apr 2021
ATAGI reinforce recommendations on use of COVID-19 vaccines following review of vaccine safety data and benefits
23 April 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) on use of COVID-19 vaccines following ...
Posted by Michael Wonder on 24 Apr 2021
AstraZeneca’s COVID-19 vaccine: benefits and risks in context
23 April 2021 - Vaxzevria (formerly COVID-19 Vaccine AstraZeneca) is authorised in the EU to prevent COVID-19, which can cause ...
Posted by Michael Wonder on 24 Apr 2021
FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review
23 April 2021 - Agencies underscore confidence in vaccine’s safety and effectiveness following data assessment; available data suggest potential blood clots ...
Posted by Michael Wonder on 21 Apr 2021
Brisbane man treated for blood clots after receiving vaccine
21 April 2021 - Queensland health authorities are investigating blood clots in a man who received the Pfizer vaccine this ...
Posted by Michael Wonder on 20 Apr 2021
Negative news on AstraZeneca to impact the ‘hesitant’ Australians
20 April 2021 - After months of monitoring the shifting winds of vaccine sentiment, last week Tauel Harper observed a ...
Posted by Michael Wonder on 20 Apr 2021
COVID-19 vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
20 April 2021 - EMA confirms overall benefit-risk remains positive ...
Posted by Michael Wonder on 19 Apr 2021
Fauci says he expects a decision Friday on whether the U.S. can resume using Johnson & Johnson’s vaccine
18 April 2021 - A decision about whether to resume administering the Johnson & Johnson COVID-19 vaccine should come this ...
Posted by Michael Wonder on 16 Apr 2021
AstraZeneca ChAdOx1-S COVID-19 vaccine
16 April 2021 - Third Australian case of thrombosis with thrombocytopenia likely linked to vaccine. ...
Posted by Michael Wonder on 15 Apr 2021
Central Coast woman’s death after COVID-19 vaccine being investigated
15 April 2021 - Federal health authorities are investigating the death of a woman days after she received a COVID-19 ...
Posted by Michael Wonder on 14 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
14 April 2021 - EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination ...
Posted by Michael Wonder on 14 Apr 2021
COVID-19 vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
14 April 2021 - As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots ...
Posted by Michael Wonder on 13 Apr 2021
U.S. FDA to scrutinise vaccine design behind COVID-19 shots linked to blood clots
13 April 2021 - With two COVID-19 vaccines now under scrutiny for possible links to very rare cases of blood ...
Posted by Michael Wonder on 13 Apr 2021
Did Australia get it right on AstraZeneca?
14 April 2021 - The almost-total absence of criticism for Australia’s decision to preference Pfizer’s vaccine over AstraZeneca’s for people ...
Posted by Michael Wonder on 13 Apr 2021
Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
13 April 2021 - The following statement is attributed to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation ...